← Back to Search

Needling Device

Straberi Epistamp Needling Treatment for Postinflammatory Hyperpigmentation (EPH Trial)

N/A

Waitlist Available

Led By Maurice E Wright, MD

Research Sponsored by Universal Skincare Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

EPH Trial Summary

This trialtests a new device to reduce the dark spots caused by acne.

Eligible Conditions

Postinflammatory Hyperpigmentation

EPH Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

The Global Aesthetic Improvement Scale (GAIS)

Secondary outcome measures

Overall Skin improvement assessed by Derma Scan

Overall Skin improvement assessed by Post Acne Hyperpigmentation Index (PAHPI)

Photographs

+1 more

EPH Trial Design

2Treatment groups

Experimental Treatment

Group I: Straberi Epistamp Needling TreatmentExperimental Treatment1 Intervention

Non-Randomized treatment for patients with Postinflammatory Hyperpigmentation (PIH) using the Straberi Epistamp needling.

Group II: No TreatmentExperimental Treatment1 Intervention

Non-Randomized patients with Postinflammatory Hyperpigmentation (PIH)

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Straberi Epistamp

2022

N/A

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Universal Skincare InstituteLead Sponsor

2 Previous Clinical Trials

55 Total Patients Enrolled

Lavish BeautyUNKNOWN

2 Previous Clinical Trials

55 Total Patients Enrolled

Leslie L NesbittStudy ChairUniversal Skincare

2 Previous Clinical Trials

55 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the study accept participants above a certain age threshold?

"This clinical trial is actively seeking patients aged between 21 and 65 years old."

Answered by AI

What is the aggregate amount of individuals participating in this experiment?

"That is correct. According to the information available on clinicaltrials.gov, this medical study was first posted on November 21st 2022 and has been actively recruiting since then. Thirty individuals are needed at one particular location for this trial."

Answered by AI

Who is eligible to become part of this research trial?

"Candidates aged between 21 and 65 that suffer from postinflammatory hyperpigmentation are eligible to take part in this trial. The study is looking for a total of 30 patients."

Answered by AI

Are there vacancies available for this trial to join?

"Correct. Clinicaltrials.gov has evidence that this medical trial, originally posted on November 21st 2022, is recruiting participants at present time. 30 volunteers need to be recruited from one centre."

Answered by AI

Recent research and studies

Clinical and Experimental DermatologyJournal

Dermatology Life Quality Index (dlqi)-a Simple Practical Measure for Routine Clinical Use

FINLAY, A.Y., and G.K. KHAN. 1994. “Dermatology Life Quality Index (dlqi)-a Simple Practical Measure for Routine Clinical Use”. Clinical and Experimental Dermatology. Wiley. doi:10.1111/j.1365-2230.1994.tb01167.x.

clinicaltrials.govStudy

Straberi Epistamp Device for Postinflammatory Hyperpigmentation

2022. "Straberi Epistamp Device for Postinflammatory Hyperpigmentation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04740255.